SEC Form D private-offering filing

Vogenx, Inc.

Name: Vogenx, Inc. - new SEC Form D private-offering filing, Raleigh, NC
Published: 2026-01-07

A new SEC Form D private-offering notice from Raleigh, NC, a $5,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Vogenx, Inc. site↗ Verified via SEC Form D

Clinical-stage biopharmaceutical company developing therapies for metabolic and gastrointestinal disorders, including its lead SGLT1 inhibitor candidate mizagliflozin for post-bariatric hypoglycemia and gastroparesis.

Filed 2026-01-07Filed to raise $5,000,000First money in 2025-12-10Raised so far $750,000HQ (as filed) Raleigh, NCSector Biotech ✓Stage (inferred) EarlyCall status Debt-only offering

Source linked the Form D on EDGAR↗Website verified vogenx.com↗Named in the filing 6 executives & directors

Open this row on the live feed →More new filings in North Carolina →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.